Skip to main content

Want a detailed portfolio tracker?

Performance analysis of Clearmind Medicine (CMND)

Annual Return

Over the past 3 years, CMND has had an average annual return of -92.81%, underperforming the benchmark SPY, which returned +22.45% annual.

Since Aug 16, 2021, CMND has had an average annual return of -81.55%, underperforming the benchmark SPY, which returned +13.04% annual.

202620252024202320222021
-86.36%-96.66%-50.93%-97.04%+519.60%-26.88%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2026+18.18%-46.15%-14.29%-25.00%-55.56%-25.00%-86.36%
2025+0%-12.29%-14.36%-2.42%-4.76%-6.52%+11.16%+5.44%-2.78%-22.45%-80.53%-70.27%-96.66%
2024-49.14%+7.76%-25.27%+3.27%-4.93%+48.70%-1.25%-21.06%-6.87%+13.89%-6.48%+6.12%-50.93%
2023+12.97%-9.24%-64.51%-51.74%+4.50%-18.10%-7.37%-11.08%-59.10%-23.80%-4.29%-19.73%-97.04%
2022-8.73%-3.33%-33.28%+0.21%-0.02%-7.88%-71.10%+202.53%-13.33%+3,662.86%-51.01%-18.35%+519.60%
2021+0%-4.95%-10.57%+1.07%-14.89%-26.88%

Drawdown analysis of Clearmind Medicine (CMND)

The maximum drawdown for the CMND was -100.00%, occurring on May 19, 2026. This drawdown has not yet recovered.

The current CMND drawdown is -100.00%.

Since Aug 16, 2021 CMND has experienced the following drawdowns:

  • 50% or more: 2 times
  • 40% or more: 2 times
  • 30% or more: 2 times
  • 20% or more: 2 times
  • 10% or more: 2 times
DepthStartTo BottomBottomTo RecoverEndTotal
-100.00%Oct 26, 2022892May 19, 2026OngoingOngoingOngoing
-93.08%Sep 7, 2021194Jun 14, 202280Oct 11, 2022274
-5.50%Oct 11, 20221Oct 12, 20224Oct 18, 20225
-0.90%Sep 2, 20211Sep 3, 20211Sep 7, 20212